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supervise!and!train!and!easier!to!disseminate (Wilson, 1996). Manualized 







































































































































































































































































context! of! depression! and! requires! intensive! time! resources! and! training.!!
Bucci! et! al.! (2016)! concluded! that! due! to! the! small! amount! of! studies!
reviewing! the!validity!of! formulations!and! the!diversity!of! validation!methods!
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1! Present! 62.2%! 94.6%! .002!
! Absent! 37.8%! 5.4%! !
2! Present! 62.2%! 94.6%! .002!
! Absent! 37.8%! 5.4%! !
3! Present! 62.2%! 81.1%! .118!
! Absent! 37.8%! 18.9%! !
4! Present! 35.1%! 91.8%! <.001!
! Absent! 64.9%! 8.1%! !
5! Present! 45.9%! 73%! .041!
! Absent! 54.1%! 27%! !
6! Present! 67.6%! 100%! *!
! 93!
! Absent! 32.4%! 7! !
7! Present! 45.9%! 86.5%! .001!
! Absent! 54.1%! 13.5%! !
8! Present! 62.2%! 100%! *!
! Absent! 37.8%! 7! !
9! Present! 21.6%! 83.8%! <.001!
! Absent! 78.4%! 16.2%! !
Total! Present! 51.7%! 89.5%! <.001!





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Individual case formulation (ICF) also referred to as ‘formulation’  is the method a therapist uses to synthesise research evidence with the
needs of the individual client to create a focus in therapeutic work. The development of ICF skills is considered to be an essential part of
training. There is however little research around how therapists acquire ICF skills. As ICF skills are considered a vital part of therapy it is
important to understand how to develop these skills. This project aims to establish in what way ICF skills improve with training as reflected
in changes in the diagrams used to represent formulations. The sample will be High Intensity (HI) trainees on the Cognitive Behavioural
Therapy (CBT) course accredited by the British Association for Behavioural and Cognitive Psychotherapies (BABCP).  As part of the
training course, the trainees attend a one-day workshop on formulation. The formulation diagrams created by the trainee therapist’ pre and
post the workshop will be scored on criteria considered important in developing the skills of formulation. Clinical supervisors will also
independently judge the participant’s ICF skills both before and after the workshop. It is expected that the formulation diagrams will exhibit
more items deemed important in developing a formulation after the training session. It is also expected that the independent ratings of ICF
skills will increase after the training session. The formulation exercises that the trainees complete in the workshop will be used in the
analysis and the trainees will be asked to fill out feedback forms. Following this a single case experimental design will be used to assess
anonymised routinely collected outcome data to judge if attending the workshops had an impact on the clinical outcome for the training
cases covering a period of both before and after the workshop.
 
Research method summary:
This project will be separated into two parts. Study 1 will be concerned with the impact of training on formulation and study 2 will investigate
the impact of training on treatment outcomes.
 
Study 1
Participants will submit the formulation of one of their training cases that they had been asked to bring along to the workshop. The
participants will then be asked to re-formulate the same case at the end of the workshop.  Participants will also be asked to complete a
formulation based on an example case vignette both pre and post the workshop as part of the training. The study will use a pre-post design
to assess participant’s formulation skills before and after the formulation workshop. The rating team will assess the trainee’s formulations
both pre and post the training on the collaborative case conceptualisation rating scale (Padesky, Kuyken & Dudley, 2011). Clinical
supervisors will also be asked to score the trainees formulations on the collaborative case conceptualisation rating scale (Padesky, Kuyken
& Dudley, 2011) during weekly supervision.
 
Study 2
A single case design methodology will be used to examine the effect of the formulation workshops presented in study one on the clinical
outcomes for the participants trainee cases. An A-B Single case experimental design (SCED) using multiple baselines will be applied to the
routinely collected clinical outcomes for the HI- trainees. The ‘A’ phase refers to the period prior to the formulation workshop and ‘B’ phase
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The study will be conducted in the context of a formulation workshop in which my academic supervisor will be teaching. The participants are
however adults working within the NHS and will be required to give informed consent and reminded that they are free to withdraw from the
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Ms Danelle Pettman 
Researcher/Postgraduate Student  
Camden & Islington NHS Foundation Trust  
Clinical Psychology Department 
Royal Holloway, University of London 





31 August 2016 
 
Dear Danelle Pettman  
 
 
Study title: The Impact of Formulation Training on Cognitive Behavioural 
Therapist's Formulation skills and Clinical Outcomes 
IRAS project ID: 208947  
Protocol number: N/A 
Sponsor Royal Holloway  
 
I am pleased to confirm that HRA Approval has been given for the above referenced study, on the 
basis described in the application form, protocol, supporting documentation and any clarifications 
noted in this letter.  
 
Participation of NHS Organisations in England  
The sponsor should now provide a copy of this letter to all participating NHS organisations in England.  
 
Appendix B provides important information for sponsors and participating NHS organisations in 
England for arranging and confirming capacity and capability. Please read Appendix B carefully, in 
particular the following sections: 
x Participating NHS organisations in England – this clarifies the types of participating 
organisations in the study and whether or not all organisations will be undertaking the same 
activities 
x Confirmation of capacity and capability - this confirms whether or not each type of participating 
NHS organisation in England is expected to give formal confirmation of capacity and capability. 
Where formal confirmation is not expected, the section also provides details on the time limit 
given to participating organisations to opt out of the study, or request additional time, before 
their participation is assumed. 
x Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) - this provides detail on the form of agreement to be used in the study to confirm 
capacity and capability, where applicable. 
Further information on funding, HR processes, and compliance with HRA criteria and standards is also 
provided. 
 
Letter of HRA Approval 
! 161!
!
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It is critical that you involve both the research management function (e.g. R&D office) supporting each 
organisation and the local research team (where there is one) in setting up your study. Contact details 
and further information about working with the research management function for each organisation 
can be accessed from www.hra.nhs.uk/hra-approval.  
 
Appendices 
The HRA Approval letter contains the following appendices: 
x A – List of documents reviewed during HRA assessment 
x B – Summary of HRA assessment 
 
After HRA Approval 
 
The attached document “After HRA Approval – guidance for sponsors and investigators” gives 
detailed guidance on reporting expectations for studies with HRA Approval, including:  
x Working with organisations hosting the research 
x Registration of Research 
x Notifying amendments 
x Notifying the end of the study 
 
The HRA website also provides guidance on these topics and is updated in the light of changes in 
reporting expectations or procedures. 
 
Scope  
HRA Approval provides an approval for research involving patients or staff in NHS organisations in 
England.  
 
If your study involves NHS organisations in other countries in the UK, please contact the relevant 
national coordinating functions for support and advice. Further information can be found at 
http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/. 
  
If there are participating non-NHS organisations, local agreement should be obtained in accordance 
with the procedures of the local participating non-NHS organisation. 
 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the application 
procedure. If you wish to make your views known please email the HRA at hra.approval@nhs.net. 
Additionally, one of our staff would be happy to call and discuss your experience of HRA Approval.  
 
HRA Training 
We are pleased to welcome researchers and research management staff at our training days – see 
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Copy to: Ms Lucy Caton, Royal Holloway University of London, Sponsor Contact 
  
Noclor, Lead NHS R&D Contact 
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Appendix A - List of Documents 
 
The final document set assessed and approved by HRA Approval is listed below.   
 
Document   Version   Date   
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Indemnity insurance]  
v1.0  18 May 2016  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Insurance certificate ]  
  19 May 2016  
IRAS Application Form [IRAS_Form_03062016]    03 June 2016  
Letters of invitation to participant [Initial Contact]  v1.1  18 May 2016  
Other [Statement of Intent submitted to RH Research Sub 
committee 25.08.2015]  
v1.0  28 August 2015  
Other [Statement of Intent approval recieved from RH Research 
Sub committee]  
v1.0  18 September 2015  
Other [Research Proposal Submitted to RH Research Sub 
Committee]  
v1.0  02 December 2015  
Other [Provisional Approval from RH Research Sub Committee]  v1.0  15 January 2016  
Other [Reply to RH Research Sub Committee]  v1.0  11 February 2016  
Other [RH Research Sub Committee Approval Letter]  v1.0  12 February 2016  
Other [Demographic Info Sheet ]  v1.1  26 May 2016  
Other [Email confirming HRA Approval required]    19 August 2016  
Other [Email with decision tool ]    19 August 2016  
Other [Schedule of Events]  2  20 August 2016  
Other [NHS to NHS form]      
Other [Statement of Activities]  2  30 August 2016  
Participant consent form [Consent Form]  v1.1  18 May 2016  
Participant consent form [ICF]  1.2  20 August 2016  
Participant information sheet (PIS) [Participant Information Sheet]  v1.1  18 May 2016  
Participant information sheet (PIS) [PIS]  1.2  20 August 2016  
Research protocol or project proposal [Research Proposal 
Submitted to RH Research Sub Committee]  
v1.0  02 December 2015  
Research protocol or project proposal [Protocol ]  1.1  26 August 2016  
Summary CV for Chief Investigator (CI) [Summary CV Danelle 
Pettman]  
v1.0  18 May 2016  
Summary CV for student [Summary CV Danelle Pettman]  v1.0  18 May 2016  
Validated questionnaire [GAD_7]  v1.0  18 May 2016  
Validated questionnaire [PHQ_9]  v1.0  18 May 2016  
Validated questionnaire [CCCRSv5]  v1.0  18 May 2016  
   
! 164!
!
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Appendix B - Summary of HRA Assessment 
 
This appendix provides assurance to you, the sponsor and the NHS in England that the study, as 
reviewed for HRA Approval, is compliant with relevant standards. It also provides information and 
clarification, where appropriate, to participating NHS organisations in England to assist in assessing 
and arranging capacity and capability. 
For information on how the sponsor should be working with participating NHS organisations in 
England, please refer to the, participating NHS organisations, capacity and capability and 
Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) sections in this appendix.  
The following person is the sponsor contact for the purpose of addressing participating organisation 
questions relating to the study: 
 
Lucy Caton (01784 414317, Lucy.Caton@rhul.ac.uk)  
 
HRA assessment criteria  
Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
1.1 IRAS application completed 
correctly 
Yes No comments   
    
2.1 Participant information/consent 
documents and consent 
process 
Yes No comments 
 
    
3.1 Protocol assessment 
 
Yes No comments 
 
    
4.1 Allocation of responsibilities 
and rights are agreed and 
documented  
Yes The applicant has provided a statement 
of activities to act as agreement of 
participating NHS organisations to take 
part in the study. 
4.2 Insurance/indemnity 
arrangements assessed 
Yes Where applicable, independent 
contractors (e.g. General Practitioners) 
should ensure that the professional 
indemnity provided by their medical 
defence organisation covers the 
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Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
4.3 Financial arrangements 
assessed  
Yes The applicant has confirmed in the 
statement of activities that the sponsor 
will not provide any funding to sites  
    
5.1 Compliance with the Data 
Protection Act and data 
security issues assessed 
Yes No comments 
 
5.2 CTIMPS – Arrangements for 
compliance with the Clinical 
Trials Regulations assessed 
Not Applicable No comments 
 
5.3 Compliance with any 
applicable laws or regulations 
Yes No comments 
 
6.1 NHS Research Ethics 
Committee favourable opinion 
received for applicable studies 
Not Applicable No comments 
 
6.2 CTIMPS – Clinical Trials 
Authorisation (CTA) letter 
received 
Not Applicable No comments 
 
6.3 Devices – MHRA notice of no 
objection received 
Not Applicable No comments 
6.4 Other regulatory approvals 
and authorisations received 
Not Applicable No comments 
 
 
Participating NHS Organisations in England 
This provides detail on the types of participating NHS organisations in the study and a statement as to whether 
the activities at all organisations are the same or different.  
There is one site type for the research, all sites will undertake the same activity.  
  
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
organisations in England in order to put arrangements in place to deliver the study. The documents 
should be sent to both the local study team, where applicable, and the office providing the research 
management function at the participating organisation. For NIHR CRN Portfolio studies, the Local 
LCRN contact should also be copied into this correspondence.  For further guidance on working with 
participating NHS organisations please see the HRA website. 
 




IRAS project ID 208947 
 
Page 7 of 7 
 
participating NHS organisations in England which are not provided in IRAS or on the HRA website, 
the chief investigator, sponsor or principal investigator should notify the HRA immediately at 
hra.approval@nhs.net. The HRA will work with these organisations to achieve a consistent approach 
to information provision.  
 
Confirmation of Capacity and Capability  
This describes whether formal confirmation of capacity and capability is expected from participating NHS 
organisations in England. 
Participating NHS organisations in England will be expected to formally confirm their capacity 
and capability to host this research.  
x Following issue of this letter, participating NHS organisations in England may now confirm to 
the sponsor their capacity and capability to host this research, when ready to do so. How 
capacity and capacity will be confirmed is detailed in the Allocation of responsibilities and 
rights are agreed and documented (4.1 of HRA assessment criteria) section of this appendix.  
x The Assessing, Arranging, and Confirming document on the HRA website provides further 
information for the sponsor and NHS organisations on assessing, arranging and confirming 




Principal Investigator Suitability 
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is correct for each 
type of participating NHS organisation in England and the minimum expectations for education, training and 
experience that PIs should meet (where applicable). 
Local collaborators will be expected at site to facilitate access for external researchers. 
 
GCP training is not a generic training expectation, in line with the HRA statement on training 
expectations. 
 
HR Good Practice Resource Pack Expectations 
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-engagement checks 
that should and should not be undertaken 
Honorary research contracts and letters of access will not be expected as external staff will only 
access non-clinical areas and have contact with staff and anonymous data.  
 
Other Information to Aid Study Set-up  
This details any other information that may be helpful to sponsors and participating NHS organisations in 
England to aid study set-up. 









































































































































































































































































































































































































































































































































































































































































































































































































































































1! ! 2! ! 3! ! 4!
!
3)!Perceived!Usefulness![1=Not!useful_!4=Very!useful]!







































1.  Feeling nervous, anxious, or on edge   0   1   2   3  
2.  Not being able to stop or control worrying   0   1   2   3  
3.  Worrying too much about different things   0   1   2   3  
4.  Trouble relaxing   0   1   2   3  
5.  Being so restless that it's hard to sit still   0   1   2   3  
6.  Becoming easily annoyed or irritable   0   1   2   3  
7.  Feeling afraid as if something awful might 
happen  
0   1   2   3  
Add the score for each column   +  +  +    



































# = % &0(1 + +1(,+0 + +1 !
!!
C=!cut7off!for!clinically!significant!change,!s0=!Standard!Deviation!(SD)!of!the!
‘functional!population’,!s1!=!SD!of!pre7intervention!‘dysfunctional!population’,!
Mo!=!Mean!of!the!‘functional!population’!and!M1!=!mean!of!pre7intervention!
‘dysfunctional!population’.!!
!
!
!
!
!
!
!
!
!
! 193!
Appendix'T.'Scree'plot'of'the'eigenvalues'of'the'ICFURS'components.''
!
Figure&X:!Scree!plot!of!principal!components!analysis!for!the!ICF7RS !
!
